Vaccines are a Lousy Business … or Not

Interesting duelling factoids in a NY Times article on why the vaccine market is, or maybe is not, a good market. On the one hand you have Wyeth whose Prevnar (a vaccine against the pneumococcal bacteria that can cause pneumonia, meningitis and ear infections) is expected to have sales topping $1 billion this year.

On other hand, you have this noteworth point from the piece:

Total sales of all vaccines worldwide are around $8 billion, less than sales of Pfizer’s Lipitor cholesterol-lowering pill alone.

Related posts:

  1. The Apprentice: Sam, or Just Lousy Male Team?
  2. Agenda-based business reporting
  3. Greatest Business movies ever
  4. Business School Rankings
  5. Small business, Mike Kinsley, and G.W. Bush